Want to track BEAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Beam Therapeutics Inc. (BEAM) Statistics
Valuation metrics
Market Cap 3.18B
Enterprise value 2.79B
Trailing P/E (ttm) -43.02
Forward P/E -
PEG ratio -0.29
Price/Sales (ttm) 17.27
Price/Book (mrq) 2.44
Enterprise Value/Revenue 17.04
Enterprise Value/EBITDA -87.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.91M
Average volume (90 days) 2.14M
Price summary
52-Week low 15.6
52-Week high 38.26
Beta -
50-Day moving average 30.4
200-Day moving average 28.33
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.4%
Operating margin -2.27%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0.22
Current ratio (mrq) 16.99%
Book value per share (mrq) 11.28
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
